Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9E3V

Backbone Modification in the Fungal Defensin Plectasin: Prototype NZ2114

9E3V の概要
エントリーDOI10.2210/pdb9e3v/pdb
関連するPDBエントリー3E7U 6K50
NMR情報BMRB: 31207
分子名称Fungal defensin plectasin variant NZ2114 (1 entity in total)
機能のキーワードplectasin derivative, defensin, antibiotic, antimicrobial protein
由来する生物種Pseudoplectania nigrella (Ebony cup)
タンパク質・核酸の鎖数1
化学式量合計4423.07
構造登録者
Harmon, T.W.,Song, J.,Gulewicz, A.J.,Di, Y.P.,Horne, W.S. (登録日: 2024-10-24, 公開日: 2025-01-08, 最終更新日: 2025-03-19)
主引用文献Harmon, T.W.,Song, J.,Gulewicz, A.J.,Di, Y.P.,Horne, W.S.
Structural and Functional Mimicry of the Antimicrobial Defensin Plectasin by Analogues with Engineered Backbone Composition.
Chembiochem, 26:e202400951-e202400951, 2025
Cited by
PubMed Abstract: The threat posed by bacteria resistant to common antibiotics creates an urgent need for novel antimicrobials. Non-ribosomal peptide natural products that bind Lipid II, such as vancomycin, represent a promising source for such agents. The fungal defensin plectasin is one of a family of ribosomally produced miniproteins that also exert antimicrobial activity via Lipid II binding. Made up entirely of canonical amino acids, these molecules are potentially more susceptible to degradation by protease enzymes than non-ribosomal counterparts. Here, we report the development of proteomimetic variants of plectasin through the systematic incorporation of artificial backbone connectivity in the domain. An iterative secondary-structure-based design scheme yields a variant with a tertiary fold indistinguishable from the prototype natural product, potent activity against Gram positive bacteria, and low mammalian cell toxicity. Backbone modification is shown to improve oxidative folding efficiency of the disulfide-rich scaffold as well as resistance to proteolytic hydrolysis. These results broaden the scope of design strategies toward protein mimetics as well as folds and biological functions possible in such agents.
PubMed: 39714882
DOI: 10.1002/cbic.202400951
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 9e3v
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon